Warmed, Humidified Carbon Dioxide Insufflation vs Standard Carbon Dioxide in Laparoscopic Cholecystectomy

October 3, 2023 updated by: Klugsberger Bettina, Kepler University Hospital

Warmed, Humidified Carbon Dioxide Insufflation vs Standard Carbon Dioxide in Laparoscopic Cholecystectomy: a Double-blinded Randomized Controlled Trial

The purpose of this study is to determine the effect of warmed, humidified carbon dioxide Insufflation vs standard carbon dioxide in laparoscopic cholecystectomy.

Study Overview

Detailed Description

Patients undergoing warmed, humidified carbon dioxide (CO2) insufflation for laparoscopic cholecystectomy will have less postoperative pain than patients undergoing laparoscopic cholecystectomy with standard CO2 insufflation. The study design is a double-blind, prospective, randomized study comparing patients undergoing laparoscopic cholecystectomy with standard CO2 insufflation vs those receiving warmed, humidified CO2. Main variables included postoperative pain (rated with a visual analog scales) and analgesic requirements.

Study Type

Interventional

Enrollment (Actual)

148

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Upper Austria
      • Linz, Upper Austria, Austria, 4020
        • 2nd Surgical Department, Academic Teaching Hospital, AKH Linz

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Clinical diagnosis of cholecystolithiasis

Exclusion Criteria:

  • Clinical diagnosis of cholecystolithiasis with cholecystitis

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: group B: Insufflation with warm gas
Insufflation with warmed, humidified carbon dioxide insufflation during laparoscopic cholecystectomy using the optitherm® device attached to the insufflation equipment in all of the patients but was only activated by the single scrub nurse in those patients randomized to group B.
The use of Optitherm® device, which was attached to the insufflation equipment in all of the patients but was only activated by the single scrub nurse in those patients randomized to group B.
Other Names:
  • Optitherm® device (Storz, Tuttlingen, Germany)
Experimental: group A: Insufflation with cold gas
group A: Insufflation with cold gas during laparoscopic cholecystectomy, the use of Optitherm® device, which was attached to the insufflation equipment in all of the patients but was inactivated in group A
The use of Optitherm® device, which was attached to the insufflation equipment in all of the patients but was inactivated in group A.
Other Names:
  • Optitherm® device (Storz, Tuttlingen, Germany)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain (Rated With a Visual Analog Scale for Pain)
Time Frame: operation day

postoperative pain (rated with a visual analog scale for pain) and analgesic requirements at operation day.

The visual analog scale for pain ranged from 0-10 (0 is no pain, 10 is Maximum of pain)

operation day
Pain (Rated With a Visual Analog Scale for Pain)
Time Frame: first postoperative day

postoperative pain (rated with a visual analog scale for pain) and analgesic requirements at operation day.

The visual analog scale for pain ranged from 0-10 (0 is no pain, 10 is Maximum of pain)

first postoperative day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Core Temperature
Time Frame: one day postoperativly
one day postoperativly
Core Temperature
Time Frame: during operation
core temperature during laparoscopic cholecystectomy using a rectal probe
during operation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Andreas Shamiyeh, Univ-Doz Dr, Ludwig Boltzmann Institute for Operative Laparoscopy, 2nd Surgical Department, Academic Teaching Hospital, AKH Linz

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2011

Primary Completion (Actual)

July 1, 2013

Study Completion (Actual)

September 1, 2013

Study Registration Dates

First Submitted

July 27, 2012

First Submitted That Met QC Criteria

August 14, 2012

First Posted (Estimated)

August 17, 2012

Study Record Updates

Last Update Posted (Actual)

October 5, 2023

Last Update Submitted That Met QC Criteria

October 3, 2023

Last Verified

October 1, 2023

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cholecystolithiasis

Clinical Trials on Optitherm® device activated

Subscribe